World Congress of Endourology and Uro-Technology: Webinar 3 (2021)
Minimally invasive urology encompasses highly technologic and rapidly evolving minimally invasive treatment options. As such, practitioners are in need of a forum that introduces state-of-the-art techniques, technologies and medical management strategies from both an evidence-based and technical skills standpoint.
At the conclusion of the 2021 Annual Meeting, participants will be able to:
- Describe recent developments in the medical management, non-invasive and minimally invasive surgical management of urologic diseases.
- Integrate the latest guidelines on the management of urologic conditions into clinical practice.
- Identify new technologies for the management of benign and malignant urologic conditions.
- Incorporate new techniques into surgical practice for a variety of urologic problems.
- Analyze outcome data and critically appraise medical and surgical options for the treatment of urologic conditions using evidence-based medicine.
Saturday, November 6, 2021
9:00am - 10:00am Unique Waveform Technology for Holmium Laser Lithotripsy
Surgeons: Moti Duvdevani, MD; Bhaskar Somani, MD & Khurshid Ghani, MD
Moderator: Michelle Jo Semins, MD & Silvia Proietti, MD
10:00am - 11:00am HoLEP using a 150W Ho:YAG laser
Surgeon: Marawan El Tayeb, MD
Moderator: Michael Borofsky, MD
Discussant: Naeem Bhorjani, MD
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Mitigation of Identified Conflict of Interest: All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:
- Peer review for valid, evidence-based content by the AUA COI Review Work Group.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
- Selection of alternative faculty for specific topic
Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
AUA PARTICIPANT INFORMATION & POLICIES
Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.
Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.
Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Non-Physician Participation